Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F8N8P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,318
Award facts
- Contract value 100% obligated
- $35,317.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $35,317.88, was awarded on January 30, 2026, to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) for the supply of Zepbound 7.5 mg/0.5 ml pen injections. The contract is funded by the Defense Logistics Agency (DLA), a Department of Defense procurement organization, with performance to be completed by February 2, 2026, at the awardee's facility in Conshohocken, Pennsylvania. This award was made on a competitive, non-set-aside basis and reflects the firm fixed-price delivery order structure typical of DLA pharmaceutical procurements.
This delivery order is issued under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC serves as the primary vehicle for delivering a broad range of pharmaceutical products and medical supplies to support military healthcare operations globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The company's portfolio demonstrates significant capability in fulfilling federal medical supply requirements for military treatment facilities and other Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F8N8P?
SPE2DR26F8N8P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F8N8P worth?
The government has obligated $35,318 on SPE2DR26F8N8P.
Is contract SPE2DR26F8N8P an order under another contract?
Yes. SPE2DR26F8N8P is a delivery order under SPE2DR25D3022, an indefinite delivery contract.
Was contract SPE2DR26F8N8P competed?
The extent of competition for SPE2DR26F8N8P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award